0001209191-23-028114.txt : 20230508
0001209191-23-028114.hdr.sgml : 20230508
20230508200945
ACCESSION NUMBER: 0001209191-23-028114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230504
FILED AS OF DATE: 20230508
DATE AS OF CHANGE: 20230508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibson Daniel Glenn
CENTRAL INDEX KEY: 0001866133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40497
FILM NUMBER: 23899581
MAIL ADDRESS:
STREET 1: C/O CODEX DNA, INC.
STREET 2: 9535 WAPLES STREET, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Telesis Bio Inc.
CENTRAL INDEX KEY: 0001850079
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 451216839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9535 WAPLES STREET
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-228-4115
MAIL ADDRESS:
STREET 1: 9535 WAPLES STREET
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Codex DNA, Inc.
DATE OF NAME CHANGE: 20210309
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-04
0
0001850079
Telesis Bio Inc.
TBIO
0001866133
Gibson Daniel Glenn
C/O CODEX DNA, INC.
10431 WATERIDGE CIRCLE, SUITE 150
SAN DIEGO
CA
92121
0
1
0
0
Chief Technology Officer
0
Common Stock
2023-05-04
4
S
0
1190
2.8261
D
102083
D
Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") and does not represent a discretionary sale by the Reporting Person.
Represents the weighted average share price of shares sold in the price range of $2.75 to $2.925 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The reporting person has reported a prior award of RSUs in Table II of Form 4. The total reported in Column 5 includes the 20,910 RSUs previously reported in Table II, and 81,173 shares of common stock.
/s/ Rob Cutler, as Attorney-in-Fact
2023-05-08